
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum Corp demonstrates a positive growth outlook through its commitment to market development, particularly within its MedSurg segment, which dominates revenue generation by enhancing healing methods and reducing overall healthcare costs. The company's strategy includes accelerating the global adoption of its antimicrobial solutions and improving the standard of care, which positions it strongly within the healthcare sector. Additionally, significant growth is anticipated in the Revenue Cycle Management segment due to expanded capabilities, continuous product innovation, and a strategic shift toward autonomous coding and international markets.
Bears say
Solventum Corp has faced a significant challenge, evidenced by seven consecutive quarters of negative volume growth prior to its spin-off, indicating a persistent decline in demand for its products. The company is projected to experience further financial strain, with an anticipated gross margin decline of approximately 40 basis points in 2026, largely attributed to the impact of tariffs. These fundamental issues suggest underlying operational weaknesses and potential instability in revenue generation, raising concerns about the company's future financial performance.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares